Publications by authors named "Timothy Wiegand"

Claim this Profile
L
Low-dose Initiation of Buprenorphine in Hospitalized Patients on Full Agonist Opioid Therapy: A Retrospective Observational Study.
Rachel F Schult, Kaylee M Maynard, Jenna M Corvelli, Stephen Rappaport, Benjamin McKinney, Timothy J Wiegand

J Addict Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe outcomes following pediatric cannabis intoxication: a prospective cohort study of an international toxicology surveillance registry.
Neta Cohen, Mathew Mathew, Jeffrey Brent, Paul Wax, Adrienne L Davis, Timothy J Wiegand

Clin Toxicol (Phila)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid emulsion therapy during management of the critically-ill poisoned patient: a prospective cohort study.
Michael Levine, Jeffrey Brent, Timothy Wiegand, Bryan Maguire, Neta Cohen

Clin Toxicol (Phila)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Buprenorphine Dose and the Urine "Norbuprenorphine" to "Creatinine" Ratio: Revised.
Hiroko Furo, Timothy Wiegand, Meenakshi Rani, Diane G Schwartz, Ross W Sullivan

Subst Abuse· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of severe outcome following opioid intoxication in children.
Neta Cohen, Mathew Mathew, Adrienne Davis, Jeffrey Brent, Paul Wax, Timothy J Wiegand

Clin Toxicol (Phila)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACMT Position Statement: Allow Optimal Treatment for Healthcare Professionals with Opioid Use Disorder.
Ryan T Marino, Meghan Spyres, Timothy J Wiegand, Kavita M Babu, Andrew Stolbach

J Med Toxicol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report.
Meghan B Spyres, Lynn A Farrugia, A Min Kang, Kim Aldy, Diane P Calello, Timothy Wiegand

J Med Toxicol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experience with lower dose flumazenil at an academic medical center.
Rachel F Schult, Deena Omar, Timothy J Wiegand, Rachel M Gordetsky, Nicole M Acquisto

Am J Emerg Med· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Descriptive Analysis of Inpatient and Outpatient Cohorts Seeking Treatment After Prescription Opioid Misuse and Medical Toxicology Evaluation.
Shawn M Varney, Timothy J Wiegand, Paul M Wax, Jeffrey Brent,

J Med Toxicol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACMT Position Statement: Caring for Patients with Opioid Use Disorder during Coronavirus Disease Pandemic.
Andrew Stolbach, Maryann Mazer-Amirshahi, Evan S Schwarz, David Juurlink, Timothy J Wiegand

J Med Toxicol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Toxicology Investigators Consortium Case Registry-the 2019 Annual Report.
Meghan B Spyres, Lynn A Farrugia, A Min Kang, Kim Aldy, Diane P Calello, Timothy Wiegand

J Med Toxicol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leadership Roles in Opioid Stewardship and the Treatment of Patients with Opioid Use Disorder Among Medical Toxicologists.
Joseph E Carpenter, Brian Patrick Murray, Maryann Mazer-Amirshahi, JoAn R Laes, Nicholas Nacca, Timothy J Wiegand

J Med Toxicol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Citalopram overdose and severe serotonin syndrome in an intermediate metabolizing patient.
Rachel F Schult, Anna J Morris, Lindsey Picard, Timothy J Wiegand

Am J Emerg Med· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A New Way Forward in the Emergency Department.
Evan S Schwarz, JoAn R Laes, Timothy J Wiegand

J Med Toxicol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACMT Position Statement: Remove the Waiver Requirement for Prescribing Buprenorphine for Opioid Use Disorder.
Ryan Marino, Jeanmarie Perrone, Lewis S Nelson, Timothy J Wiegand, Evan S Schwarz

J Med Toxicol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Toxicology Investigators Consortium Case Registry-the 2018 Annual Report.
Meghan B Spyres, Lynn A Farrugia, A Min Kang, Diane P Calello, Sharan L Campleman, Timothy Wiegand

J Med Toxicol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACMT Position Statement: Buprenorphine Administration in the Emergency Department.
Paul M Wax, Andrew I Stolbach, Evan S Schwarz, Brandon J Warrick, Timothy J Wiegand

J Med Toxicol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis